A detailed history of King Wealth transactions in Abbott Laboratories stock. As of the latest transaction made, King Wealth holds 10,769 shares of ABT stock, worth $1.23 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
10,769
Previous 10,723 0.43%
Holding current value
$1.23 Million
Previous $1.11 Million 10.23%
% of portfolio
0.19%
Previous 0.19%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$100.07 - $118.13 $4,603 - $5,433
46 Added 0.43%
10,769 $1.23 Million
Q2 2024

Aug 08, 2024

BUY
$100.73 - $112.44 $4,734 - $5,284
47 Added 0.44%
10,723 $1.11 Million
Q1 2024

May 09, 2024

BUY
$109.52 - $120.96 $7,228 - $7,983
66 Added 0.62%
10,676 $1.21 Million
Q4 2023

Feb 08, 2024

BUY
$90.19 - $110.4 $6,764 - $8,280
75 Added 0.71%
10,610 $1.17 Million
Q3 2023

Nov 09, 2023

SELL
$95.53 - $114.62 $32,671 - $39,200
-342 Reduced 3.14%
10,535 $1.02 Million
Q2 2023

Aug 10, 2023

BUY
$100.78 - $112.29 $43,033 - $47,947
427 Added 4.09%
10,877 $1.19 Million
Q1 2023

May 10, 2023

BUY
$96.86 - $114.01 $2,421 - $2,850
25 Added 0.24%
10,450 $1.06 Million
Q4 2022

Feb 09, 2023

BUY
$95.06 - $111.52 $29,753 - $34,905
313 Added 3.1%
10,425 $1.15 Million
Q3 2022

Nov 10, 2022

BUY
$96.76 - $112.03 $19,545 - $22,630
202 Added 2.04%
10,112 $978,000
Q2 2022

Aug 11, 2022

BUY
$102.07 - $123.37 $2,143 - $2,590
21 Added 0.21%
9,910 $1.08 Million
Q1 2022

May 12, 2022

SELL
$114.02 - $139.04 $28,276 - $34,481
-248 Reduced 2.45%
9,889 $1.17 Million
Q4 2021

Feb 11, 2022

SELL
$115.53 - $141.46 $33,619 - $41,164
-291 Reduced 2.79%
10,137 $1.43 Million
Q3 2021

Nov 12, 2021

SELL
$116.66 - $129.06 $2,216 - $2,452
-19 Reduced 0.18%
10,428 $1.23 Million
Q2 2021

Aug 12, 2021

BUY
$105.79 - $124.53 $211 - $249
2 Added 0.02%
10,447 $1.21 Million
Q1 2021

May 14, 2021

BUY
$108.84 - $128.23 $217 - $256
2 Added 0.02%
10,445 $1.25 Million
Q4 2020

Feb 12, 2021

SELL
$105.0 - $114.42 $36,435 - $39,703
-347 Reduced 3.22%
10,443 $1.14 Million
Q3 2020

Nov 12, 2020

BUY
$91.64 - $111.29 $183 - $222
2 Added 0.02%
10,790 $1.17 Million
Q2 2020

Aug 13, 2020

BUY
$76.57 - $98.0 $15,390 - $19,698
201 Added 1.9%
10,788 $986,000
Q1 2020

May 13, 2020

BUY
$62.82 - $91.86 $4,962 - $7,256
79 Added 0.75%
10,587 $835,000
Q4 2019

Feb 13, 2020

BUY
$78.51 - $87.4 $6,437 - $7,166
82 Added 0.79%
10,508 $913,000
Q3 2019

Nov 13, 2019

BUY
$81.84 - $88.74 $9,902 - $10,737
121 Added 1.17%
10,426 $873,000
Q2 2019

Aug 13, 2019

BUY
$72.88 - $85.0 $50,797 - $59,245
697 Added 7.25%
10,305 $867,000
Q1 2019

May 13, 2019

SELL
$66.22 - $80.06 $3,642 - $4,403
-55 Reduced 0.57%
9,608 $768,000
Q4 2018

Feb 14, 2019

BUY
$65.56 - $74.27 $15,996 - $18,121
244 Added 2.59%
9,663 $699,000
Q3 2018

Nov 13, 2018

BUY
$60.81 - $73.36 $121 - $146
2 Added 0.02%
9,419 $691,000
Q2 2018

Aug 14, 2018

BUY
$57.57 - $63.54 $115 - $127
2 Added 0.02%
9,417 $574,000
Q1 2018

May 14, 2018

BUY
$56.27 - $63.62 $3,263 - $3,689
58 Added 0.62%
9,415 $564,000
Q4 2017

Feb 12, 2018

BUY
$53.68 - $57.47 $107 - $114
2 Added 0.02%
9,357 $534,000
Q3 2017

Nov 13, 2017

BUY
$48.06 - $53.64 $96 - $107
2 Added 0.02%
9,355 $499,000
Q2 2017

Aug 14, 2017

BUY
N/A
9,353
9,353 $455,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track King Wealth Portfolio

Follow King Wealth and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of King Wealth, based on Form 13F filings with the SEC.

News

Stay updated on King Wealth with notifications on news.